Trump demands transparency from pharma companies on COVID drug data, amid turmoil at CDC over vaccine policy changes.
Revolut, the UK fintech, conducts a secondary share sale at a $75 billion valuation, allowing employees to sell up to 20% of their holdings.
Premier League clubs face crucial transfer decisions as the deadline approaches, with fans calling for signings to address striking and defensive weaknesses.
Trump demands transparency from pharma companies on COVID drug data, amid turmoil at CDC over vaccine policy changes.
Revolut, the UK fintech, conducts a secondary share sale at a $75 billion valuation, allowing employees to sell up to 20% of their holdings.
Premier League clubs face crucial transfer decisions as the deadline approaches, with fans calling for signings to address striking and defensive weaknesses.